What does the future hold for Cardiovascular Research?

نویسنده

  • Karin R Sipido
چکیده

In the recent two decades, Cardiovascular Research has grown into a leading journal in the cardiovascular field. Strong leadership and regular renewal have boosted this growth. It is therefore with pride and not without some trepidation that we take over the editorial leadership. Michael Piper, David Garcia-Dorado and their team hand over a thriving journal. In their decade of leadership the journal has gone through significant transformation and has positioned itself as the basic science flagship of the European Society of Cardiology (ESC). The editors and their team have emphasized quality and impact of the published manuscripts and introduced active debate on ethics in science and publishing. They challenge the new editors to take it further forward in times that are likely to see major changes. What awaits us? To answer this we take a closer look at the nature of scientific publishing, the current (com)motions surrounding it, and the expectations of stakeholders.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of serum melatonin and albumin with cardiovascular disease

Cardiovascular diseases are a major cause of death worldwide.  Endothelial dysfunction, inflammatory conditions, and oxidative stress at the forefront of the onset and progression of most cardiovascular diseases specificaly coronary heart disease and heart failure. Melatonin is a type of indole neuroendocrine hormone.  It was first found that the regulation of the sleep-wake cycle is regulated...

متن کامل

What Does the Future Hold for Theoretical Computer Science?

Prospects for research in theoretical computer science are discussed. The maintenance of a genuine link between theory and practice is seen as key to the future health of both.

متن کامل

In vivo tracking of stem cells for clinical trials in cardiovascular disease.

Various stem cells hold promise for the treatment of human cardiovascular disease. Regardless of stem cell origin, future clinical trials will require that the location and number of such cells be tracked in vivo, over long periods of time. The problem of tracking small numbers of cells in the body is a difficult one, and an optimal solution does not yet exist. We review the many contrast agent...

متن کامل

Erythropoietin in cardioprotection: does it have a future or is it all in the past?

Over the past two decades, we have seen a gradual reduction in mortality from myocardial infarction due in a large part to the advent of revascularization and other cardioprotective strategies. However, myocardial infarction is still the most common cause of morbidity, related primarily to the loss of left ventricular function and mortality. A host of novel strategies are being examined to limi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Cardiovascular research

دوره 97 1  شماره 

صفحات  -

تاریخ انتشار 2013